US 11,690,577 B2
Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
Hari Hampapuram, Portland, OR (US); Anna Leigh Davis, Cardiff, CA (US); Naresh C. Bhavaraju, San Diego, CA (US); Apurv Ullas Kamath, San Diego, CA (US); Claudio Cobelli, Padua (IT); Giovanni Sparacino, Padua (IT); Andrea Facchinetti, Padua (IT); and Chiara Zecchin, Pernumia (IT)
Assigned to Dexcom, Inc., San Diego, CA (US)
Filed by DexCom, Inc., San Diego, CA (US)
Filed on May 27, 2020, as Appl. No. 16/884,593.
Application 16/884,593 is a continuation of application No. 16/674,979, filed on Nov. 5, 2019, granted, now 10,702,215.
Application 16/674,979 is a continuation of application No. 16/172,550, filed on Oct. 26, 2018, granted, now 10,555,705, issued on Feb. 11, 2020.
Application 16/172,550 is a continuation of application No. 15/486,704, filed on Apr. 13, 2017, granted, now 10,143,426, issued on Dec. 4, 2018.
Application 15/486,704 is a continuation of application No. 14/720,668, filed on May 22, 2015, granted, now 9,655,565, issued on May 23, 2017.
Application 14/720,668 is a continuation of application No. 13/742,841, filed on Jan. 16, 2013, granted, now 9,119,529, issued on Sep. 1, 2015.
Application 13/742,841 is a continuation of application No. 13/742,694, filed on Jan. 16, 2013, granted, now 9,119,528, issued on Sep. 1, 2015.
Claims priority of provisional application 61/720,286, filed on Oct. 30, 2012.
Prior Publication US 2020/0305804 A1, Oct. 1, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61B 5/145 (2006.01)
CPC A61B 5/746 (2013.01) [A61B 5/0004 (2013.01); A61B 5/0022 (2013.01); A61B 5/0031 (2013.01); A61B 5/14503 (2013.01); A61B 5/14532 (2013.01); A61B 5/4848 (2013.01); A61B 5/4866 (2013.01); A61B 5/7221 (2013.01); A61B 5/7275 (2013.01); A61B 5/002 (2013.01)] 226 Claims
OG exemplary drawing
 
1. A non-transitory computer readable medium for storing instructions that when executed perform a method of activating indicators based on sensor data derived from one or more signals received from a transcutaneous analyte sensor, the method comprising:
evaluating sensor data to determine whether a real time glucose value meets one or more user settable first criteria;
evaluating sensor data to determine whether a predicted glucose value meets one or more non user settable second criteria; and
providing an output including a first glycemic indicator if the one or more user settable first criteria is met, and providing an output including a second glycemic indicator if the one or more non user settable second criteria are met, wherein the first glycemic indicator and second glycemic indicator comprise a hyperglycemic indicator and wherein the one or more user settable first criteria comprise a first high threshold that is configured to be user settable and the one or more non user settable second criteria comprise a second high threshold that is not user settable.